Conmed (CNMD) Operating Expenses (2010 - 2026)

Conmed's Operating Expenses history runs 17 years deep, the most recent figure standing at $158.0 million for Q1 2026.

• Quarterly Operating Expenses fell 2.33% year-over-year to $158.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $644.1 million (up 15.52% YoY) and the FY2025 annual result came in at $647.9 million, up 21.62% from the prior year.
• Operating Expenses was $158.0 million for Q1 2026 at Conmed, down from $181.7 million in the prior quarter.
• Across five years, Operating Expenses topped out at $181.7 million in Q4 2025 and bottomed at $113.3 million in Q3 2024.
• A 5-year average of $140.9 million and a median of $137.8 million in 2023 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2024 — Operating Expenses slipped 17.76% — and 2025, when it surged 36.15%.
• Conmed's Operating Expenses stood at $133.0 million in 2022, then slipped by 0.73% to $132.0 million in 2023, then increased by 10.5% to $145.8 million in 2024, then increased by 24.56% to $181.7 million in 2025, then decreased by 13.01% to $158.0 million in 2026.
• Business Quant data shows CNMD's Operating Expenses at $158.0 million in Q1 2026, $181.7 million in Q4 2025, and $154.2 million in Q3 2025.